Blog

Phage Therapy for Diabetic Foot Infection: A Case Series in Clinical Therapeutics https://doi.org/10.1016/j.clinthera.2023.06.009 Abstract Purpose Infected diabetic foot ulcers can be difficult to treat and, despite appropriate antibiotic therapy, some…

Escherichia fergusonii strain RY44, whole genome shotgun sequencing project Title: Isolation of E. fergusonii from poultry ceca samples in College Station, Texas https://www.ncbi.nlm.nih.gov/nuccore/JASJUP000000000

Patients in India who need alternative therapy to treat antibiotic resistant infections can reach out to us. We will help you to get compassionate phage therapy. Stay tuned for the…

Another interesting study on phage therapy : "Bacteriophage therapy against pathological Klebsiella pneumoniae ameliorates the course of primary sclerosing cholangitis" Nature Communications volume 14, Article number: 3261 (2023) Abstract Primary sclerosing cholangitis (PSC) is characterized by progressive…

A retrospective, observational study of 12 cases of expanded access customized phage therapy: production, characteristics, and clinical outcomes Clinical Infectious Diseases, ciad335 Abstract Background Antibiotic resistance (AMR) is undermining modern…

Abstract Our previous studies have shown that high alcohol-producing Klebsiella pneumoniae (HiAlc Kpn) in the intestinal microbiome could be one of the causes of non-alcoholic fatty liver disease (NAFLD). Considering antimicrobial resistance of K.…

Advancements in bacteriophage therapies and delivery for bacterial infection DOI: 10.1039/D2MA00980C (Review Article) Mater. Adv., 2023, 4, 1249-1257 Abstract Having co-evolved with bacteria over hundreds of millions of years, bacteriophage are effective killers of…

Case report: Analysis of phage therapy failure in a patient with a Pseudomonas aeruginosaprosthetic vascular graft infection https://doi.org/10.3389/fmed.2023.1199657 Clinical case of a patient with a Pseudomonas aeruginosa multidrug-resistant prosthetic vascular graft infection which…

AMR was associated with nearly 5 million deaths in 2019, however the R&D pipeline for new antibiotics is thin and access to new and existing treatments remains a challenge.  WHO,…

Phages—tiny entities that infect bacteria—were discovered over 100 years ago but were largely abandoned as therapies. Now they’re making a comeback. Bacteriophages—or phages for short—are microscopic viruses even smaller than…